Aperio Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$808K Buy
4,669
+144
+3% +$23.3K ﹤0.01% 1707
2020
Q3
$631K Buy
4,525
+215
+5% +$28.7K ﹤0.01% 1681
2020
Q2
$515K Sell
4,310
-331
-7% -$39.3K ﹤0.01% 1761
2020
Q1
$464K Buy
4,641
+891
+24% +$107K ﹤0.01% 1690
2019
Q4
$441K Sell
3,750
-334
-8% -$33.1K ﹤0.01% 1869
2019
Q3
$351K Buy
4,084
+578
+16% +$43.7K ﹤0.01% 1949
2019
Q2
$227K Buy
+3,506
New +$218K ﹤0.01% 2133
2016
Q4
Sell
-2,352
Closed -$246K 2138
2016
Q3
$246K Buy
+2,352
New +$212K ﹤0.01% 1826

Other funds holding NVRO

Aperio Group's NVRO Position: Q4 2020 in Review

Aperio Group increased its NEVRO CORP. (NVRO) stake by 3.2% in Q4 2020, buying an estimated $23.3K and bringing the position to 4,669 shares worth $808K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Aperio Group first reported a position in NVRO in Q3 2016 and has held it in 8 quarters since. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • Aperio Group held 4,669 shares of NEVRO CORP. worth $808K as of Q4 2020.
  • Aperio Group bought 144 NEVRO CORP. shares in Q4 2020, an estimated $23.3K.
  • NEVRO CORP. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1707 holding.
  • Aperio Group first reported a position in NEVRO CORP. in Q3 2016 and has held it in 8 quarters since.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.